Article
Spatially resolved whole-transcriptomic profiling of EGFR-mutated lung adenocarcinomas stratified by PD-L1 expression.
Cellular oncology (Dordrecht, Netherlands) - 22 Dec 2025
Yu Chenxi, Shi Chenxi, Zhou Hao, Li Na, Ma Ruyi, Liu SongBai, Tang Zaixiang, Zhang Xianling, Lei Zhe, Qin Hualong
Abstract excerpt
PURPOSE: High programmed death-ligand 1 (PD-L1) expression is associated with unfavorable clinical outcomes in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinomas (LUAD) patients treated with tyrosine kinase inhibitors (TKIs) or anti-PD-1/PD-L1 therapy, yet the underlying mechanisms are less explored. METHODS: Bulk RNA sequencing (RNA-seq) datasets were analyzed to investigate intertumoral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
